Your browser doesn't support javascript.
loading
An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12.
Papp, K; Maari, C; Cauthen, A; Gooderham, M; Spelman, L; Yamanaka, K; Polzer, P; Zhang, L; Osuntokun, O; Augustin, M.
Affiliation
  • Papp K; K. Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada.
  • Maari C; Innovaderm Research, Montreal, QC, Canada.
  • Cauthen A; MidState Skin Institute, Ocala, FL, U.S.A.
  • Gooderham M; SkiN Centre for Dermatology and Probity Medical Research, Peterborough, and Queens University, Kingston, ON, Canada.
  • Spelman L; Veracity Clinical Research, Brisbane, Queensland, Australia.
  • Yamanaka K; Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Mie, Japan.
  • Polzer P; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Zhang L; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Osuntokun O; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Augustin M; Institute for Health Services Research in Dermatology and Nursing, University Medical Center, Hamburg, Germany.
Br J Dermatol ; 183(1): 52-59, 2020 07.
Article in En | MEDLINE | ID: mdl-31545506
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Psoriasis Type of study: Clinical_trials Limits: Adult / Humans Country/Region as subject: Asia Language: En Journal: Br J Dermatol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Psoriasis Type of study: Clinical_trials Limits: Adult / Humans Country/Region as subject: Asia Language: En Journal: Br J Dermatol Year: 2020 Document type: Article Affiliation country: Country of publication: